GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Waverley Pharma WAVE.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.02

—

Close of 2 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Waverley Pharma — daily TSXV:WAVE Delayed
Market value
C$1.1m
Last close × shares
Volume
6k
Shares, 2 Nov 2026

About Waverley Pharma

Its shares trade on TSX Venture under the ticker WAVE.V. It has been listed since 27 April 2017. In the fiscal year to 31 December 2025, it reported revenue of C$1.3m and a net loss of C$499,214. At that date it held total assets of C$1.2m and shareholders' equity of −C$2.6m.

Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. The company is headquartered in Winnipeg, Manitoba. The company went IPO on 2017-04-27. The firm is focused on the generic oncology injectable market in Europe, the United Kingdom, and North America. Its generic oncology product is bortezomib. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Its other generic oncology product, pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma. In addition to the development of pemetrexed and bortezomib, it also focuses on acquiring rights to six additional products for the United States market. The brands represented by these six generic products, referred to by the Company as WAV-103, WAV-104, WAV-105, WAV-106, WAV-107 and WAV-108. The company also sells products, including capecitabine, temozolomide, and erlotinib.

Figures and description from our data supplier, not checked against the company's own report.

More about Waverley Pharma →

Latest on Waverley Pharma

Our reporting

We have not reported on Waverley Pharma yet.

Next results

25 Nov 2026

Due on 25 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Waverley Pharma's ticker?

Waverley Pharma trades as WAVE.V on TSX Venture, under ISIN CA94357L1058.

What was Waverley Pharma's last closing price?

0.02 on 2 Nov 2026. The figure is in CAD and is never converted.

When does Waverley Pharma next report results?

Results are expected on 25 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.